THE CYSTIC-FIBROSIS DELTA-F508 GENE-MUTATIONS AND CANCER

Citation
Ra. Padua et al., THE CYSTIC-FIBROSIS DELTA-F508 GENE-MUTATIONS AND CANCER, Human mutation, 10(1), 1997, pp. 45-48
Citations number
19
Categorie Soggetti
Genetics & Heredity
Journal title
ISSN journal
10597794
Volume
10
Issue
1
Year of publication
1997
Pages
45 - 48
Database
ISI
SICI code
1059-7794(1997)10:1<45:TCDGAC>2.0.ZU;2-7
Abstract
Following the observation that relatives of cystic fibrosis (CF) patie nts have an increased mortality due to leukaemia, a study was initiate d to determine whether leukaemia patients had an increased prevalence of the Delta F508 CF mutation. No increase in carriers were found amon g leukaemias; however the carrier frequency of the Delta F508 mutation appeared to be reduced in patients with malignant melanoma analysed a s a control group compared to the normal population. This paper extend s our previous study and investigates several other common human tumou rs, including those of the colon, breast, and lymphoma tissue. Fewer t han expected carriers remained among the melanoma group from South Wal es. There were fewer than expected carriers among patients with colon cancer compared to the normal population. The prevalence of the Delta F508 mutation was normal in lymphomas and leukaemias. (C) 1997 Wiley-L iss, Inc.